| 前收市價 | 1.3000 |
| 開市 | 0.9000 |
| 買盤 | 0.5500 |
| 賣出價 | 1.5000 |
| 拍板 | 82.50 |
| 到期日 | 2024-12-20 |
| 今日波幅 | 0.9000 - 0.9000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 513 |
Barrons.comBioNTech Is More Than a Covid-19 Stock. It’s Having a Great September.
Recently BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry upside down.
Investor's Business DailyHow BioNTech, Up 26% Over Four Days, Is Riding Summit's Coattails To A Recovery
BioNTech stock has climbed 26% over four days as the German biotech rides a round of cancer treatment success from Summit Therapeutics.
Motley FoolHere's Why Everyone's Talking About Summit Therapeutics
Find out why positive results from a Summit Therapeutics study keep pushing up BioNTech and Instil Bio stock.
